Leanbio y Syna ....... a tener muy en cuenta 

Intas’ Biologics Business Unit was launched in 2000 with a focus on developing high-quality recombinant DNA protein (rDNA) products and plasma-derived products. Its robust product portfolio consists of 13 commercialized products and a promising pipeline of 6 products. Intas’ biosimilars are registered in more than 20 countries and under registration in more than 30 countries through strategic marketing alliances. Every biological product is developed in India’s first EU approved biotech plant.

SOBRE INTAS Pharmaceuticals ........  Currently, Intas has over 10,000 product registrations worldwide. In India, Intas has established leadership in key therapeutic segments like CNS, Cardiovascular, Diabetology, Gastroenterology, Urology, Oncology, Haematology, Immunology and Neurology. Overseas, the company is particularly well known for its range of products in Oncology and other hospital – based therapeutic areas in the EU and USA

Objetivo conseguido. Ahora ya cierro la boca una temporada, a ver si sube, porque cada vez que compro ...............

alguien me puede vender 300 ? orden puesta. s2s. Si se me hace, objetivo cumplido

Tendremos que esperar al viernes. Ahora toca tontear con el 3

Ya podríais remar un poco...